Press Releases
Clovis Oncology Announces Negative Outcome of CO-101 in Pivotal LEAP Pancreatic Cancer Study
Clovis Oncology, Inc. today announced the results from its LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 versus gemcitabine in metastatic pancreatic cancer. There was no difference in overall survival between the...
Press Releases
S.M.A.R.T.® Vascular Stent Systems Receive FDA Approval for Use in SFA
Cordis Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved the S.M.A.R.T.® CONTROL® Vascular Stent Systems for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery (PPA). The...
Press Releases
Rethinking Body Mass Index (BMI) For Assessing Cancer Risk
A study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that body mass index (BMI)—the most commonly used weight-for-height formula for estimating fatness—may not be the best measure for estimating disease risk, and particularly...
Press Releases
LipoScience Presents Scientific Data Highlighting New Findings Related to Lipoprotein Particles
LipoScience, Inc., an in vitro diagnostic company committed to advancing patient care in cardiovascular, metabolic and other diseases, today presented key findings related to lipoprotein particles (LDL-P) and cardiovascular disease at the Annual Meeting of the American Heart...
Press Releases
Hagens Berman: Pennsylvania Woman with Fungal Meningitis Sues Drug Manufacturer
A Red Lion, Pennsylvania woman stricken with fungal meningitis filed a lawsuit last Friday in federal court against New England Compounding Center (“NECC”), its sister company Ameridose LLC and its sales arm Medical Sales Management, seeking to hold...
Press Releases
Significant Blood Pressure Reduction from St. Jude Medical’s EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months
St. Jude Medical, Inc., a global medical device company, today announced that the company’s EnligHTN™ renal denervation system provided a safe, effective and sustained reduction in office and ambulatory blood pressure measurements at six months. The new data...
Press Releases
Curie-Cancer and Harmonic Pharma sign a partnership agreement for exploring the anti-cancer activity of several compounds
Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities and Harmonic Pharma, which is developing solutions for extending the therapeutic application of compounds already on the market, announce today that they have entered into a research...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read